Publikation

Tacrolimus monitoring in hair samples of kidney transplant recipients.

Wissenschaftlicher Artikel/Review - 04.12.2023

Bereiche
PubMed
DOI
Kontakt

Zitation
Born A, Bocchi F, Kuhn C, Amstutz U, Baumgartner M, Sidler D. Tacrolimus monitoring in hair samples of kidney transplant recipients. Front Med (Lausanne) 2023; 10:1307505.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Front Med (Lausanne) 2023; 10
Veröffentlichungsdatum
04.12.2023
ISSN (Druck)
2296-858X
Seiten
1307505
Kurzbeschreibung/Zielsetzung

Calcineurin inhibitors, including tacrolimus, remain a cornerstone of immunosuppressive therapy after kidney transplantation. However, the therapeutic window is narrow, and nephrotoxic side effects occur with overdose, while the risk of alloimmunization and graft rejection increases with underdose. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) allows quantification of tacrolimus in biological samples from patients. This study investigates the feasibility of quantifying tacrolimus in scalp hair from kidney transplant (KT) recipients and correlates hair tacrolimus concentrations with tacrolimus dosage and blood trough levels. The aim was to provide proof-of-principle for hair tacrolimus drug monitoring in KT recipients.